Evidence map›Paper›PMID 30367383›Full record

ReviewJournal of neuro-oncology2019

Fluorescence-guided surgery with aminolevulinic acid for low-grade gliomas.

Benjamin K Hendricks, Nader Sanai, Walter Stummer

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in Journal of neuro-oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05850377 (5-Aminolevulinic Acid), which is not on this map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05850377 unknown statusnot on this mapstarted 2023, after this paper: background citation

5-Aminolevulinic Acid (5-ALA) Gliolan®: Usage Increase Proposal for Neurosurgical Procedures in High-Grade Gliomas

TypeobservationalSponsorSociedad de Lucha Contra el Cáncer del EcuadorRan2023 to 2026Enrolled90ConditionsHigh Grade Glioma, Glioma, Glioma, Malignant, Neoplasms, NeuroepithelialArms5-Aminolevulinic Acid (5-ALA) Gliolan®, Fluorescence-Guided Surgery using 5-aminolevulinic acid (5-ALA)
3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 28 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. GliomaCancers · 2021
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Benjamin K HendricksBarrow Neurological Institute, Phoenix, AZ, USA.ORCID http://orcid.org/0000-0002-7123-4387
Nader SanaiBarrow Neurological Institute, Phoenix, AZ, USA.
Walter StummerDepartment of Neurosurgery, University of Münster, Münster, Germany. Walter.Stummer@ukmuenster.de.
Barrow Neurological Institute · USUniversity of Münster · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionFluorescence guided surgery has developed over the last 2 decades as a formidable augmentation strategy to promote maximal safe resection and diagnostic accuracy within gliomas. The majority of the literature evidence supporting this modality utilizes 5-aminolevulinic acid in the setting of high-grade gliomas. The role for fluorescence guided surgery in low-grade gliomas is less well defined.

resultsThis review describes the existing literature discussing the utilization of 5-aminolevulinic acid for fluorescence guided surgery in low-grade gliomas, including its pertinence in identification of anaplastic foci and potential role in guiding resection following combination with augmentation strategies for detection.

conclusionThe advance in operative technology and growth of research analyzing 5-aminolevulinic acid will continue to enhance the role of fluorescence guided surgery within the standard of surgical management for low-grade gliomas.

Indexed as

Aminolevulinic AcidBrain NeoplasmsFluorescent DyesGliomaHumansMicroscopy, FluorescenceNeuronavigationTreatment OutcomeAminolevulinic AcidFluorescent DyesAnaplastic fociFluorophoreMicroscopyMicrosurgeryProtoporphyrin

Identifiers

PMID30367383
OpenAlexW2898252817

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.